Home/Filings/4/0001628280-23-008798
4//SEC Filing

Dempsey James F. 4

Accession 0001628280-23-008798

CIK 0001597313other

Filed

Mar 20, 8:00 PM ET

Accepted

Mar 21, 6:22 PM ET

Size

22.0 KB

Accession

0001628280-23-008798

Insider Transaction Report

Form 4
Period: 2022-10-24
Dempsey James F.
DirectorChief Scientific Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-03-03$0.75/sh+42,000$31,500696,368 total
  • Sale

    Common Stock

    2023-03-03$4.13/sh42,000$173,460654,368 total
  • Exercise/Conversion

    Common Stock

    2023-03-07$0.75/sh+125,000$93,750779,368 total
  • Award

    Performance Units

    2023-03-01+86,40586,405 total
    Exercise: $0.00Common Stock (86,405 underlying)
  • Tax Payment

    Common Stock

    2023-03-01$4.12/sh14,872$61,273694,068 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2023-03-03$0.75/sh42,000$31,500292,305 total
    Exercise: $0.75Exp: 2024-04-11Common Stock (42,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2023-03-07$0.75/sh125,000$93,750167,305 total
    Exercise: $0.75Exp: 2024-04-11Common Stock (125,000 underlying)
  • Tax Payment

    Common Stock

    2022-10-24$4.30/sh37,681$162,028642,165 total
  • Tax Payment

    Common Stock

    2023-03-01$4.12/sh19,630$80,876708,940 total
  • Tax Payment

    Common Stock

    2023-03-02$4.12/sh39,700$163,564654,368 total
  • Award

    Common Stock

    2023-03-01+86,405728,570 total
Footnotes (6)
  • [F1]Payment of tax liability by withholding securities incident to vesting of restricted stock units.
  • [F2]The reported securities are RSUs that entitle the Reporting Person to receive one share of Common Stock per RSU upon vesting. A total of one-third of the shares subject to this grant become vested on each of the first three anniversaries of March 1, 2023, subject to the Reporting Person remaining a service provider through each such vesting date.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.090 to $4.145, inclusive. The reporting person undertakes to provide ViewRay, Inc., any security holder of ViewRay, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]Includes 774,426 shares granted as RSUs. As of the transaction date, 294,131 of the RSUs have vested.
  • [F5]These performance share awards were issued at a 100% target and have a 3-year vest period and will vest in all or in part upon achievement of performance metrics. Any awards that have not been vested and released at the end of the 3-year period will be cancelled.
  • [F6]All of the shares subject to this option are fully vested and exercisable as of the date of exercise.

Issuer

ViewRay, Inc.

CIK 0001597313

Entity typeother

Related Parties

1
  • filerCIK 0001637089

Filing Metadata

Form type
4
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 6:22 PM ET
Size
22.0 KB